Stavros Stavrakis to Risk Assessment
This is a "connection" page, showing publications Stavros Stavrakis has written about Risk Assessment.
Connection Strength
1.008
-
Predictors of Adverse Outcomes in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy: A Meta-Analysis of Observational Studies. Cardiol Rev. 2019 Jul/Aug; 27(4):189-197.
Score: 0.549
-
Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis. J Cardiovasc Electrophysiol. 2018 05; 29(5):725-732.
Score: 0.125
-
Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Electrophysiol. 2017 Jun; 28(6):659-665.
Score: 0.118
-
Development and validation of a prognostic index for risk stratification of patients with early repolarization. Ann Noninvasive Electrocardiol. 2012 Oct; 17(4):361-71.
Score: 0.085
-
Transesophageal echocardiography for the diagnosis of pulmonary vein stenosis after catheter ablation of atrial fibrillation: a systematic review. Echocardiography. 2010 Oct; 27(9):1141-6.
Score: 0.075
-
Clinical characteristics and long-term clinical course of patients with Brugada syndrome without previous cardiac arrest: a multiparametric risk stratification approach. Europace. 2019 12 01; 21(12):1911-1918.
Score: 0.035
-
Coronary slow flow--prevalence and clinical correlations. Circ J. 2012; 76(4):936-42.
Score: 0.021